Trexquant Investment LP Aerie Pharmaceuticals Inc Transaction History

Trexquant Investment LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $124,667 - $183,146	-11,013 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$15.16 - $18.97 $82,819 - $103,633	-5,463 Reduced 33.16%	11,013 $176,000
Q1 2021 May 13, 2021	BUY	$13.12 - $20.9 $66,951 - $106,652	5,103 Added 44.87%	16,476 $294,000
Q4 2020 Feb 11, 2021	BUY	$9.12 - $14.49 $103,721 - $164,794	11,373 New	11,373 $154,000
Q1 2020 May 08, 2020	SELL	$11.84 - $25.52 $196,851 - $424,295	-16,626 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$17.72 - $25.1 $294,612 - $417,312	16,626 New	16,626 $402,000
Q3 2019 Nov 08, 2019	SELL	$18.41 - $28.0 $276,242 - $420,140	-15,005 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$28.97 - $48.21 $434,694 - $723,391	15,005 New	15,005 $443,000
Q3 2018 Nov 09, 2018	SELL	$56.15 - $73.9 $303,266 - $399,133	-5,401 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$47.85 - $70.45 $1.15 Million - $1.7 Million	-24,115 Reduced 81.7%	5,401 $365,000
Q1 2018 May 03, 2018	BUY	$51.15 - $61.0 $1.3 Million - $1.55 Million	25,422 Added 620.96%	29,516 $1.6 Million
Q4 2017 Feb 09, 2018	BUY	$50.85 - $65.1 $208,179 - $266,519	4,094	4,094 $245,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.